GF
Therapeutic Areas
Genefirst Pipeline
| Drug | Indication | Phase |
|---|---|---|
| JAK2 Mutation Test Kit | Myeloproliferative Neoplasms (JAK2 V617F mutation) | Commercial |
| ABL Mutation Test Kit | Chronic Myeloid Leukemia (ABL T315I mutation) | Commercial |
| HR-HPV DNA Test | Cervical Cancer Screening (14 high-risk HPV types) | Commercial |
| HR-HPV mRNA Test | Cervical Cancer Risk Stratification | Commercial |
| Lower Airway Panel | Community-Acquired Pneumonia (9 pathogens) | Commercial |
| Upper Airway Panel | Upper Respiratory Tract Infection (11 pathogens) | Commercial |
| ATOM-Seq cfDNA/FFPE Assays | Cancer Genomic Profiling | Commercial |